{
  "docId": "019de070-35c1-7439-bbdc-1b157563e1ac",
  "docSlug": "efb4ac2b8ef2465cd20aa5f0f0b26fe6",
  "documentTitle": "Poseida Therapeutics | IPO Presentation Deck | 34 slides",
  "authorId": "poseida-therapeutics",
  "authorName": "Poseida Therapeutics",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investment_bank",
  "sourceTypeLabel": "Investment bank",
  "presentationDate": "2020-07-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 10,
  "pageCount": 34,
  "prevPage": 9,
  "nextPage": 11,
  "slideType": "competitive_analysis",
  "function": "compare_peers",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "The slide uses a categorization framework to map competitors against specific therapeutic modalities (Cell Therapies, Gene Therapies, Other).",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de070-35c1-7439-bbdc-1b157563e1ac/10",
  "deckHref": "/decks/019de070-35c1-7439-bbdc-1b157563e1ac",
  "deckJsonHref": "/decks/019de070-35c1-7439-bbdc-1b157563e1ac.json",
  "deckAnchorHref": "/decks/019de070-35c1-7439-bbdc-1b157563e1ac#slide-10",
  "components": [
    {
      "bbox": {
        "h": 0.1,
        "w": 0.64,
        "x": 0.18,
        "y": 0.2
      },
      "kind": "diagram",
      "text": "piggyBac DNA Modification System, Cas-CLOVER Gene Editing System, Nanoparticle/AAV Delivery Technology",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "af1c48cd-fecc-492d-b7be-bab52ab45d69",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.45,
        "w": 0.84,
        "x": 0.13,
        "y": 0.45
      },
      "kind": "image",
      "text": "Juno, Kite, Allogene, Fate, BlueRock, bluebirdbio, Ambys, AveXis, Audentes, Spark, PassageBio, Inovio, CRISPR, Editas, Intellia, Beam, Moderna, Alnylam",
      "attrs": null,
      "subkind": "logo-grid",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b8025166-d3a7-4a77-838b-99fea4dddc38",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.5,
        "x": 0.25,
        "y": 0.32
      },
      "kind": "paragraph",
      "text": "Our Gene Engineering Platform Technologies Enable Opportunities in Many Segments Where Multiple Other Biotech Companies Are Seeing Success",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c99de92a-cfc1-4367-94d6-abb724716bca",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.35,
        "x": 0.03,
        "y": 0.94
      },
      "kind": "source-note",
      "text": "Poseida has listed companies it believes are representative of those active in cell and gene therapy.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "00b89779-0ff4-4f52-8abe-83467704cadc",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.07,
        "w": 0.78,
        "x": 0.03,
        "y": 0.05
      },
      "kind": "title",
      "text": "Platform Technologies Fuel Significant Growth Potential",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "07b7cff1-c653-4a91-986b-0352da3f6d34",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "2x2 matrix",
      "slug": "matrix-2x2",
      "agent": null,
      "layer": "slide",
      "matchId": "41c943a6-a969-4e00-80d1-d17c0b0ca741",
      "evidence": "image/logo-grid: Juno, Kite, Allogene, Fate, BlueRock, bluebirdbio, Ambys, AveXis, Audentes, Spark, PassageBio, Inovio, CRISPR, Editas, Intellia, Beam, Moderna, Alnylam",
      "confidence": 0.7
    }
  ],
  "frameworks": [
    {
      "name": "market-segmentation-pyramid",
      "slug": null,
      "matchId": "38dfe5f3-e256-4d91-8e23-4dc594b33e64",
      "evidence": "Categorization of therapeutic modalities into segments and sub-segments.",
      "confidence": 0.7
    }
  ],
  "arcBeats": [
    {
      "to": 10,
      "from": 10,
      "beatId": "636440d3-a27b-460e-b849-ee6d826cec52",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Market Size",
      "beatSlug": "sequoia-pitch-market-size",
      "evidence": "Platform Technologies Fuel Significant Growth Potential",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}